Author:
Parghane Rahul V.,Basu Sandip
Abstract
Abstract
Prostate carcinoma (PC) is the second most common malignant tumor in males globally. The metastatic spread of PC usually involves the pelvic and abdominal lymph nodes and the skeletal system. Cutaneous metastases are exceedingly uncommon and typically manifest themselves late in the disease course, considered as ominous sign with limited treatment options and a poor prognosis. We describe a patient wherein 68Ga-PSMA-11 PET/CT detected multiple uncommon metastatic sites in the cutaneous region of the scrotum, penis, and thigh, as well as in the subcutaneous region of anterior abdominal wall, and in bilateral adrenal glands. These findings served as a theranostic tool for selecting 177Lu-PSMA-617 treatment for these extremely rare metastatic sites.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference6 articles.
1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;CA Cancer J Clin,2021
2. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients;Hum Pathol,2000
3. Cutaneous metastasis: a meta-analysis of data;South Med J,2003
4. Cutaneous metastases in progressive prostate adenocarcinoma: a case report and literature review;Cureus,2023
5. Cutaneous metastasis of prostate adenocarcinoma: a rare presentation of a common disease;J Investig Med High Impact Case Rep,2021